Browsing Tag
Suvorexant
1 post
Bajaj Healthcare (NSE: BAJAJHCARE) Q3 FY26 earnings: API exports double, PAT up 34%
Bajaj Healthcare’s API exports doubled in Q3 FY26, driving 31% revenue growth. Find out what its CNS pipeline and CDMO ramp mean for future expansion.